These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 22836630)
1. Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis. Lewandowska K; Ciurzynski M; Gorska E; Bienias P; Irzyk K; Siwicka M; Zycinska K; Pruszczyk P; Demkow U Adv Exp Med Biol; 2013; 756():147-53. PubMed ID: 22836630 [TBL] [Abstract][Full Text] [Related]
2. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Pignone A; Scaletti C; Matucci-Cerinic M; Vázquez-Abad D; Meroni PL; Del Papa N; Falcini F; Generini S; Rothfield N; Cagnoni M Clin Exp Rheumatol; 1998; 16(5):527-32. PubMed ID: 9779298 [TBL] [Abstract][Full Text] [Related]
3. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. Negi VS; Tripathy NK; Misra R; Nityanand S J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764 [TBL] [Abstract][Full Text] [Related]
4. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Ihn H; Sato S; Fujimoto M; Igarashi A; Yazawa N; Kubo M; Kikuchi K; Takehara K; Tamaki K Clin Exp Immunol; 2000 Jan; 119(1):203-9. PubMed ID: 10606984 [TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension? Arends SJ; Damoiseaux JG; Duijvestijn AM; Debrus-Palmans L; Vroomen M; Boomars KA; Brunner-La Rocca HP; Reutelingsperger CP; Cohen Tervaert JW; van Paassen P Clin Exp Immunol; 2013 Dec; 174(3):433-40. PubMed ID: 23815467 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956 [TBL] [Abstract][Full Text] [Related]
10. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis. Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411 [TBL] [Abstract][Full Text] [Related]
11. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Dib H; Tamby MC; Bussone G; Regent A; Berezné A; Lafine C; Broussard C; Simonneau G; Guillevin L; Witko-Sarsat V; Humbert M; Mouthon L Eur Respir J; 2012 Jun; 39(6):1405-14. PubMed ID: 22005913 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Vemulapalli S; Cohen L; Hsu V Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465 [TBL] [Abstract][Full Text] [Related]
13. Anti-endothelial cell antibodies in patients with interstitial lung diseases. Matsui T; Inui N; Suda T; Chida K Respir Med; 2008 Jan; 102(1):128-33. PubMed ID: 17851060 [TBL] [Abstract][Full Text] [Related]
14. Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease. Lage LV; de Carvalho JF; Caleiro MT; Yoshinari NH; da Mota LM; Khamashta MA; Cossermelli W Isr Med Assoc J; 2012 Feb; 14(2):84-7. PubMed ID: 22693786 [TBL] [Abstract][Full Text] [Related]
15. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Wusirika R; Ferri C; Marin M; Knight DA; Waldman WJ; Ross P; Magro CM Am J Clin Pathol; 2003 Oct; 120(4):596-606. PubMed ID: 14560571 [TBL] [Abstract][Full Text] [Related]
16. [Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis]. Doveri M; Frassi F; Consensi A; Vesprini E; Gargani L; Tafuri M; Picano E; Della Rossa A; Delle Sedie A; d'Ascanio A; Giacomelli C; Bazzichi L; Bombardieri S Reumatismo; 2008; 60(3):180-4. PubMed ID: 18854878 [TBL] [Abstract][Full Text] [Related]
17. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. Hamaguchi Y J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839 [TBL] [Abstract][Full Text] [Related]
18. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620 [TBL] [Abstract][Full Text] [Related]
19. Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. Del Papa N; Quirici N; Scavullo C; Gianelli U; Corti L; Vitali C; Ferri C; Giuggioli D; Manfredi A; Maglione W; Onida F; Colaci M; Bosari S; Lambertenghi Deliliers G J Rheumatol; 2010 Oct; 37(10):2053-63. PubMed ID: 20716660 [TBL] [Abstract][Full Text] [Related]
20. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Riccieri V; Germano V; Alessandri C; Vasile M; Ceccarelli F; Sciarra I; Di Franco M; Spadaro A; Valesini G Clin Exp Rheumatol; 2008; 26(6):992-7. PubMed ID: 19210861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]